Cancer
Targeted Therapies Enhance Long-Term Survival in Lung Cancer Patients with Rare Genetic Mutations
In the relentless pursuit of advancing cancer treatment, a groundbreaking study has emerged from the Mass General Brigham Cancer Institute,...
Unraveling Colitis-Linked Colorectal Cancer Mechanisms
Colitis-associated colorectal cancer (caCRC) represents a compelling and increasingly significant subset of colorectal malignancies, arising predominantly in patients afflicted with...
Metabolic Enzyme Identified as Key Predictor of Cancer Immunotherapy Success—Opening Doors for Enhanced Patient Response
Immunotherapy has revolutionized cancer treatment by empowering the immune system to recognize and destroy malignant cells. Despite its promise, this...
Correcting Clock and Bmal1’s Role in Cancer Cells
In a groundbreaking advancement that deepens our understanding of cellular mechanics in cancer, researchers have unveiled how the circadian clock...
New Study Uncovers Risks of ‘Anti-Aging’ Supplements in Cancer Prevention
In recent years, the widespread use of vitamin B3 derivatives such as nicotinamide mononucleotide (NMN), nicotinamide riboside (NR), and nicotinamide...
NCCN 2026 Annual Conference Equips Cancer Care Providers Globally to Embrace Holistic Patient Healing
The 2026 Annual Conference of the National Comprehensive Cancer Network (NCCN), held in Orlando, Florida, convened over a thousand oncology...
Unveiling the Biological Pathways Linking Pesticides to Cancer Risk: New Study Sheds Light on Environmental Health Impacts
A groundbreaking study recently published in Nature Health reveals a compelling and robust connection between pervasive environmental exposure to agricultural...
FGFR2b Links to Biomarkers, Tumor Diversity, Survival
In a groundbreaking study published this March, researchers have unveiled transformative insights into the role of Fibroblast Growth Factor Receptor...
Early cfEBV DNA Guides Nasopharyngeal Cancer Treatment
In a groundbreaking advancement for personalized cancer therapy, researchers have unveiled a novel approach to tailor induction chemotherapy cycles for...
Phase 1: Ceralasertib, Durvalumab in NSCLC and HNSCC
In a groundbreaking stride towards combating some of the deadliest forms of cancer, researchers have unveiled promising early results from...
Genetic Variants Driving Rapid Immune Response Associated with Earlier Breast Cancer Onset in BRCA1 Mutation Carriers
Damaging Variants in Innate Immunity Genes Markedly Accelerate Breast Cancer Onset in BRCA1 Mutation Carriers Recent preliminary findings published in...
University of Cincinnati Scientists Reveal Definitive Connection Between Chronic Kidney Disease and Periodontal Disease
Emerging research from the University of Cincinnati College of Medicine has illuminated an increasingly compelling connection between oral health and...
Impact of Food Deserts on Post-Breast Reconstruction Complications
A newly published study unveils a significant correlation between residing in food deserts and an elevated risk of complications following...
Unveiling the Hidden Defenses: How Scientists Are Battling a Deadly Childhood Cancer
In a groundbreaking advance in pediatric oncology, researchers at the University of Queensland have unveiled an unprecedented spatial map that...
Breakthrough Study Reveals New Insights into Breast Cancer Metastasis
A groundbreaking study conducted by researchers at the University of California San Diego has illuminated a novel mechanism by which...
Exploring Cancer Treatments: Insights into Risks and Side Effects
Multiple myeloma remains a formidable challenge in oncology, characterized by the uncontrolled proliferation of plasma cells within the bone marrow....
San Antonio Breast Cancer Symposium® Drives $39.6 Million Impact and Breakthroughs in Cancer Care
The San Antonio Breast Cancer Symposium® (SABCS) has once again solidified its role as a seminal event in the global...
Abemaciclib and Fulvestrant: Real-World vs MONARCH-2
In a groundbreaking study published recently in the British Journal of Cancer, researchers have provided compelling real-world evidence on the...
Combined Treatment with SCD1 Inhibitor Aramchol, Regorafenib, and Metformin Effectively Kills Uveal Melanoma Cells
A groundbreaking study published in the renowned journal Oncotarget reveals compelling evidence that the inhibition of stearoyl-CoA desaturase-1 (SCD1) by...
Key Nutrient Boosts Cancer-Fighting Ability of T Cells, Study Reveals
In a groundbreaking study published in the prestigious journal Cell, researchers from Johns Hopkins University have unveiled a nuanced metabolic...
